Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/27/2026

1. SPY
2. AKAM
3. COST
4. META
5. NVDA
6. ZS
7. AWK
8. DRI
9. ULS
10. VEON

Go back to Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1183.46 +1.57 (0.13%)
Previous Close $1181.89    52 Week High $88.16 
Open $1185.32    52 Week Low $67.88 
Day High $1190.00    P/E 273.95 
Day Low $1160.84    EPS $4.32 
Volume 1,924,379